EichorEICHOR
Condition: Uc Urothelial Cancer Synced from ClinicalTrials.gov · August 07, 2026

Recruiting studies: Uc Urothelial Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerabili
Phase 1/Phase 2 · 10 location(s) · Lumara Bio Oncologics GmbH · NCT05706129Safety and Tolerability Study of 68Ga/177Lu-BRP-020063 in Advanced Solid Tumors
EARLY_Phase 1 · 1 location(s) · Shanghai General Hospital, Shanghai Jiao Tong University Sch · NCT07439120Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer Staging
Phase N/A · 1 location(s) · Oslo University Hospital · NCT07602010Non-invasive Urinary Genomics-Based Risk Assessment for Early Urothelial Carcinoma Diagnosis
Phase N/A · 1 location(s) · Henan Provincial People's Hospital · NCT07614594Randomized Trial of stAndard of Care With or Without Metastases-directed Stereotactic Body Radiation Therapy in Patients
NA · 1 location(s) · Istituto Clinico Humanitas · NCT07413523DK222 Study at Hopkins
Phase 1 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT07140315Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Phase 1 · 122 location(s) · Exelixis · NCT05176483A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Phase 1 · 17 location(s) · IDEAYA Biosciences · NCT0727741318F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
NA · 1 location(s) · Peking University First Hospital · NCT07557225A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors
Phase 1 · 7 location(s) · Shanghai Henlius Biotech · NCT07518043A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Phase 1/Phase 2 · 3 location(s) · Arvinas Inc. · NCT07749586Korean Prospective Upper Tract Urothelial Carcinoma Cohort
Phase N/A · 1 location(s) · Samsung Medical Center · NCT07452432Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence
Phase 2 · 1 location(s) · University of California, Irvine · NCT06682728Sacituzumab Govitecan Plus EV in Metastatic UC
Phase 1/Phase 2 · 1 location(s) · Dana-Farber Cancer Institute · NCT04724018A Patient-Directed Mobile Tool to Streamline the QoL Assessment and Monitoring in Urothelial Carcinoma
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06982794Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma
Phase N/A · 1 location(s) · Tianjin Medical University Second Hospital · NCT07441499Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bl
Phase N/A · 23 location(s) · Convergent Genomics, Inc. · NCT07673016
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.